X4 Pharmaceuticals (XFOR) Shares Outstanding (2017 - 2025)

X4 Pharmaceuticals has reported Shares Outstanding for 9 years, with the latest figure at $90.9 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding rose 1495.35% year-over-year to $90.9 million; the trailing twelve-month figure through Dec 2025 stood at $90.9 million (up 1495.35% YoY), and the FY2025 full-year result was $90.9 million, up 1495.35% from the prior year.
• Shares Outstanding for Q4 2025 stood at $90.9 million, up from $25.1 million in the prior quarter.
• The five-year high for Shares Outstanding was $164.7 million in Q3 2023, with the low at $4.1 million in Q4 2022.
• Historically, Shares Outstanding has averaged $42.2 million across 5 years, with a median of $24.6 million in 2021.
• Annual changes were most pronounced in 2024 — Shares Outstanding sank 96.59% — and 2025, when it soared 1495.35%.
• X4 Pharmaceuticals' Shares Outstanding stood at $28.1 million in 2021, then plunged by 85.58% to $4.1 million in 2022, then surged by 37.62% to $5.6 million in 2023, then increased by 2.1% to $5.7 million in 2024, then soared by 1495.35% to $90.9 million in 2025.
• The last three Shares Outstanding figures came in at $90.9 million (Q4 2025), $25.1 million (Q3 2025), and $8.0 million (Q2 2025), per Business Quant data.